These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Detection of multi-drug resistance & characterization of mutations in Mycobacterium tuberculosis isolates from North- Eastern States of India using GenoType MTBDRplus assay. Singhal R, Myneedu VP, Arora J, Singh N, Sah GC, Sarin R. Indian J Med Res; 2014 Oct; 140(4):501-6. PubMed ID: 25488443 [Abstract] [Full Text] [Related]
5. Use of GenoType® MTBDRplus assay to assess drug resistance and mutation patterns of multidrug-resistant tuberculosis isolates in northern India. Maurya AK, Singh AK, Kant S, Umrao J, Kumar M, Kushwaha RA, Nag VL, Dhole TN. Indian J Med Microbiol; 2013 Oct; 31(3):230-6. PubMed ID: 23883707 [Abstract] [Full Text] [Related]
7. Early detection of multi-drug resistance and common mutations in Mycobacterium tuberculosis isolates from Delhi using GenoType MTBDRplus assay. Singhal R, Myneedu VP, Arora J, Singh N, Bhalla M, Verma A, Sarin R. Indian J Med Microbiol; 2015 Feb; 33 Suppl():46-52. PubMed ID: 25657156 [Abstract] [Full Text] [Related]
9. Trends in drug-resistant tuberculosis after the implementation of the DOTS strategy in Shenzhen, China, 2000-2013. Zhu L, Yang YZ, Guan HY, Cheng SM, Jin YY, Tan WG, Wu QF, Liu XL, Zhao MG, Lu ZH, Jia ZW. Int J Tuberc Lung Dis; 2017 Jul 01; 21(7):759-765. PubMed ID: 28633700 [Abstract] [Full Text] [Related]
11. Surveillance of Mycobacterium tuberculosis drug resistance in Hong Kong, 1986-1999, after the implementation of directly observed treatment. Kam KM, Yip CW. Int J Tuberc Lung Dis; 2001 Sep 01; 5(9):815-23. PubMed ID: 11573892 [Abstract] [Full Text] [Related]
12. Variations in rifampicin and isoniazid resistance associated genetic mutations among drug naïve and recurrence cases of pulmonary tuberculosis. Kabir S, Junaid K, Rehman A. Int J Infect Dis; 2021 Feb 01; 103():56-61. PubMed ID: 33181327 [Abstract] [Full Text] [Related]
13. Detecting mutation pattern of drug-resistant Mycobacterium tuberculosis isolates in Himachal Pradesh using GenoType(®) MTBDRplus assay. Thakur C, Kumar V, Gupta AK. Indian J Med Microbiol; 2015 Feb 01; 33(4):547-53. PubMed ID: 26470962 [Abstract] [Full Text] [Related]
15. Isoniazid and rifampicin resistance mutations and their effect on second-line anti-tuberculosis treatment. Abate D, Tedla Y, Meressa D, Ameni G. Int J Tuberc Lung Dis; 2014 Aug 01; 18(8):946-51. PubMed ID: 25199009 [Abstract] [Full Text] [Related]
16. Prevalence and factors associated with multidrug-resistant tuberculosis in South India. Shivekar SS, Kaliaperumal V, Brammacharry U, Sakkaravarthy A, Raj CKV, Alagappan C, Muthaiah M. Sci Rep; 2020 Oct 16; 10(1):17552. PubMed ID: 33067551 [Abstract] [Full Text] [Related]
17. Line probe assay for detection of rifampicin and isoniazid resistant tuberculosis in Pakistan. Farooqi JQ, Khan E, Alam SM, Ali A, Hasan Z, Hasan R. J Pak Med Assoc; 2012 Aug 16; 62(8):767-72. PubMed ID: 23862246 [Abstract] [Full Text] [Related]
18. Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosis. Park SK, Kim JH, Kang H, Cho JS, Smego RA. Int J Infect Dis; 2009 Mar 16; 13(2):170-5. PubMed ID: 18768342 [Abstract] [Full Text] [Related]